Maurice B Pensaert | Ghent University (original) (raw)
Papers by Maurice B Pensaert
Annales De Medecine Veterinaire, 1999
Aqua Culture Asia Pacific, 2010
Vlaams Diergeneeskundig Tijdschrift, 2000
Vlaams Diergeneeskundig Tijdschrift, 1976
A study was made to examine whether vaccination of cattle against Aujeszky’s disease (AD) affords... more A study was made to examine whether vaccination of cattle against Aujeszky’s disease (AD) affords protection upon subsequent intranasal challenge exposure with virulent virus. Vaccinations were performed either subcutaneously with a commercially available oil adjuvanted AD vaccine, in some cases supplemented with A1(OH3), or intranasally with the attenuated NIA-4 strain of Aujeszky’s disease virus (ADV) or intranasally with a commercially available TS mutant of BHV-1 (IBR virus). Challenge exposure was performed intranasally with 103 LD50 of the virulent AD virus. In preceding experiments, it had been found that 104.6TCID50 of this virulent AD virus strain in primary pig kidney cells represented about 1 LD50 for cattle. This LD50 was practically the same for cattle with or without antibodies against ADV prior to inoculation. In the seropositive animals, antibodies were present presumably as a consequence of a previous BHV-1 infection in the field.
Vlaams Diergeneeskundig Tijdschrift, 2001
Research in Veterinary Science, 1982
Research in Veterinary Science, Mar 1, 1990
Annales De Medecine Veterinaire, 1999
Aqua Culture Asia Pacific, 2010
Vlaams Diergeneeskundig Tijdschrift, 2000
Vlaams Diergeneeskundig Tijdschrift, 1976
A study was made to examine whether vaccination of cattle against Aujeszky’s disease (AD) affords... more A study was made to examine whether vaccination of cattle against Aujeszky’s disease (AD) affords protection upon subsequent intranasal challenge exposure with virulent virus. Vaccinations were performed either subcutaneously with a commercially available oil adjuvanted AD vaccine, in some cases supplemented with A1(OH3), or intranasally with the attenuated NIA-4 strain of Aujeszky’s disease virus (ADV) or intranasally with a commercially available TS mutant of BHV-1 (IBR virus). Challenge exposure was performed intranasally with 103 LD50 of the virulent AD virus. In preceding experiments, it had been found that 104.6TCID50 of this virulent AD virus strain in primary pig kidney cells represented about 1 LD50 for cattle. This LD50 was practically the same for cattle with or without antibodies against ADV prior to inoculation. In the seropositive animals, antibodies were present presumably as a consequence of a previous BHV-1 infection in the field.
Vlaams Diergeneeskundig Tijdschrift, 2001
Research in Veterinary Science, 1982
Research in Veterinary Science, Mar 1, 1990